Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.087 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.12 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.073 | 0.7 |
mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.055 | 0.7 |